Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q4 adjusted EBITDA drops to SEK 6.7 mln

Feb 8 (Reuters) - Xvivo Perfusion Ab  XVIVO.ST : 
    * Q4 sales 38.4 million Swedish crowns ($4.32 million) 
versus 32.7 million crowns year ago 
    * Q4 adjusted EBITDA 6.7 million crowns versus 7.2 million 
crowns year ago 
 
Source text for Eikon:  ID:nWkr6pqCXT  
Further company coverage:  XVIVO.ST  
 
($1 = 8.8803 Swedish crowns) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xvivo Perfusion AB

See all news